Financial Statements — MNTN
Balance Sheet
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q3
2025 | Q2
2025 |
|---|
| Cash & Equivalents | 237.28 | 213.90 | 179.17 | 175.16 |
| Accounts Receivable | 59.99 | 56.32 | 57.75 | 61.74 |
| Total Current Assets | 311.64 | 283.45 | 254.16 | 255.83 |
| Property, Plant & Equipment | -- | -- | 0.00 | 0.00 |
| Goodwill | 51.90 | 51.90 | 51.90 | 51.90 |
| Total Non-current Assets* | 91.10 | 91.67 | 81.72 | 81.18 |
| Total Assets | 402.74 | 375.12 | 335.88 | 337.00 |
| Accounts Payable | 53.82 | 44.32 | 54.66 | 69.71 |
| Total Current Liabilities | 64.12 | 52.14 | 62.87 | 78.08 |
| Total Non-current Liabilities* | 4.29 | 4.35 | 6.27 | 20.00 |
| Total Liabilities | 68.41 | 56.49 | 69.14 | 98.09 |
| Retained Earnings | (245.63) | (252.35) | (295.58) | (302.02) |
| Total Stockholder Equity | 334.33 | 318.63 | 266.73 | 238.92 |
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Total Revenue | 82.54 | 73.67 | 87.10 | 70.02 | 68.46 |
| Cost of Revenue | 16.24 | 13.65 | 15.63 | 14.79 | 15.90 |
| Gross Profit | 66.30 | 60.02 | 71.47 | 55.23 | 52.56 |
| Research & Development | 16.35 | 14.61 | 15.19 | 13.71 | 10.73 |
| Selling, General & Admin | 13.60 | 11.48 | 12.07 | 11.98 | 13.14 |
| Total Operating Expenses | 59.18 | 50.44 | 50.95 | 47.70 | 48.85 |
| Operating Income | 7.12 | 9.58 | 20.52 | 7.53 | 3.72 |
| Pretax Income | 9.16 | 11.62 | 25.28 | 8.38 | (24.24) |
| Tax Provision | 2.44 | 2.86 | (9.20) | 1.95 | 1.99 |
| Net Income | 6.72 | 8.76 | 34.48 | 6.44 | (26.23) |
| Basic EPS | 0.09 | 0.12 | 0.82 | 0.09 | (0.65) |
| Diluted EPS | 0.09 | 0.11 | 0.82 | 0.08 | (0.65) |
Cash Flow Statement
(in millions USD)| Metric | Q2
2026 | Q1
2026 | Q4
2025 | Q3
2025 | Q2
2025 |
|---|
| Operating Cash Flow | 26.92 | 7.11 | 29.55 | 9.33 | 17.59 |
| Investing Cash Flow | (3.55) | (3.44) | 1.70 | (3.02) | (15.80) |
| Financing Cash Flow | 0.02 | 0.07 | (0.26) | (2.30) | 90.81 |
